Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples